Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06872645 · ClinicalTrials.gov registry record · NA
Exploring Water-free Sodium Storage
A NA study of Peritoneal Dialysis, Heart Failure, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06872645: Recruiting NA study of Peritoneal Dialysis, Heart Failure, sponsored by Yale University.
NCT06872645 is a NA study of Peritoneal Dialysis, Heart Failure that is actively recruiting participants, run by Yale University. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06872645, a NA study of Peritoneal Dialysis, Heart Failure, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, and if the location is intracellular vs. extracellular.
Primary Outcome
Water free Na removal will be calculated as \[Water Free Na= ((ΔTBW (L) \* serum Na (mmol/L)) - Na balance (mmol)\]. This will be compared between 5% dextrose Na removal period and 1.5% dextrose standard PD neutral Na balance period
Conditions Studied
Interventions
- DRUG 5% Dextrose/Water
- DRUG 1.5% standard PD fluid
Study Locations (1)
Connecticut
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06872645 shows while recruiting
NCT06872645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Peritoneal Dialysis, Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which 5% Dextrose/Water is the first listed.
NCT06872645 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06872645 about?
NCT06872645 is a clinical study titled "Exploring Water-free Sodium Storage". The overarching goal of this proposal is to definitively establish if acute water free Na storage and release occurs, if the amount stored/released is of a quantity that is physiologically relevant, and if the location is intracellular vs. extracellular.
What is the current status of trial NCT06872645?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-03. Estimated completion is 2026-12.
What conditions does trial NCT06872645 study?
This clinical trial studies the following conditions: Peritoneal Dialysis, Heart Failure.
What interventions are being tested in trial NCT06872645?
The interventions under investigation include: 5% Dextrose/Water (DRUG), 1.5% standard PD fluid (DRUG).
Who is sponsoring clinical trial NCT06872645?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06872645 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06872645's enrollment target sits among peer trials
10 1928th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI